Manufacture of slow-release matrix granules by wet granulation with an aqueous dispersion of quaternary poly(meth)acrylates in the fluidized bed.
Slow-release matrix granules were manufactured in the fluidized bed using an aqueous dispersion of quaternary poly(meth)acrylates (Eudragit RS 30 D) as binder for granulation. A factorial design was carried out to investigate the influence of the following parameters, spraying rate, applied polymer amount, and inlet air temperature, on various granule properties. Prerequisites for a slow release of the model drug theophylline are high spraying rate, high amount of polymer, and low inlet air temperature. No considerable decrease of the drug release rate can be achieved without a subsequent curing of the dry granules. A clear correlation exists between the moisture content of the fluidized bed, indicated by the terminal moisture content (TMC), and the mean dissolution time for 80% of the drug (MDT80).
Radtke
Guido
G
Pharmaceutical Research & Development, Boehringer Ingelheim Pharma KG, Biberach/Riss, Germany.
Knop
Klaus
K
Lippold
Bernhard C
BC
D003692:Delayed-Action Preparations; D011109:Polymethacrylic Acids; D013678:Technology, Pharmaceutical
D003692:Delayed-Action Preparations; D011109:Polymethacrylic Acids; C030613:polymethacrylic acid